Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
UBS
Boehringer Ingelheim
Federal Trade Commission
Healthtrust
Citi
Moodys
Medtronic
Julphar

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VOLTAREN

« Back to Dashboard

Clinical Trials for Voltaren

Trial ID Title Status Sponsor Phase Summary
NCT00171691 Safety of Diclofenac Sodium Gel in Knee Osteoarthritis Completed Novartis Phase 3 This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis.
NCT00276419 Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin Terminated Mayo Clinic Phase 2/Phase 3 The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.
NCT00310908 Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic Completed Grumental Phase 4 The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
NCT00310908 Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic Completed Hadassah Medical Organization Phase 4 The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
NCT00523120 Topical Voltaren in Otitis Externa Terminated Sieff Medical Center Phase 2 Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.
NCT00715091 Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis Completed Charite University, Berlin, Germany Phase 4 This is a randomised, controlled, multi-centre clinical trial on AS patients. Experimental intervention: continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren Resinate), divided into 75mg Voltaren twice dailyControl intervention: treatment on-demand (as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment strategy of the control intervention (on-demand) reflects current clinical practice in AS. Duration of intervention per patient: 2 years Follow-up per patient: safety assessment 3 months after termination of the trial.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Voltaren

Condition Name

Condition Name for Voltaren
Intervention Trials
Pain 8
Osteoarthritis 3
Osteoarthritis, Knee 2
Osteo Arthritis of the Knee 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Voltaren
Intervention Trials
Osteoarthritis 7
Osteoarthritis, Knee 6
Renal Colic 2
Spondylitis, Ankylosing 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Voltaren

Trials by Country

Trials by Country for Voltaren
Location Trials
United States 40
India 13
Germany 6
Egypt 5
Poland 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Voltaren
Location Trials
California 3
Texas 3
Florida 2
Arizona 2
Virginia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Voltaren

Clinical Trial Phase

Clinical Trial Phase for Voltaren
Clinical Trial Phase Trials
Phase 4 10
Phase 3 12
Phase 2/Phase 3 2
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Voltaren
Clinical Trial Phase Trials
Completed 17
Recruiting 10
Terminated 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Voltaren

Sponsor Name

Sponsor Name for Voltaren
Sponsor Trials
Cairo University 4
Assiut University 2
Sristek Clinical Research Solutions Limited 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Voltaren
Sponsor Trials
Other 26
Industry 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
UBS
Johnson and Johnson
Mallinckrodt
Teva
Federal Trade Commission
Queensland Health
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.